Summary
- Current Price
- As of today, SGMO price is $0.43, down -1.75% on
- Current Price All-Time High
- SGMO price is currently -99.16% below its historical high of $51.38 set on
- Market Cap
- SGMO current market cap is $145M, down -28.81% year-over-year
- PE Ratio
- SGMO PE ratio is unknown
- Revenue
- SGMO current annual revenue is $57.80M, down -67.20% year-over-year
- Next Earnings
- The next earnings release for SGMO is on
Profile
| Metric | Value |
|---|---|
| Full Name | Sangamo Therapeutics, Inc. |
| Ticker | NASDAQ: SGMO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | sangamo.com |
| Employees | 183 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.43 | ||
| Price, 1D Change | -1.75% | |
| $145M | ||
| - | ||
| - | ||
| 1.30 | ||
| $58M | ||
| Revenue, 1Y Change | -67.20% | |
| -$0.49 | ||
| EPS, 1Y Change | +67.14% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.49 | ||
| EPS Estimate | -$0.37 | |
| EPS Est. Change | +23.13% | |
| $57.80M | ||
| Revenue Estimate | $65.55M | |
| Revenue Est. Change | +13.41% | |
| $0.43 | ||
| Price Target | - | $2.00 |
| Price Tgt. Change | - | +362.64% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.38 | -$1.48 | -7.10% | |
| - | -$0.49 | - | |
| -$0.37 | N/A | +23.13% | |
| -$0.19 | N/A | +61.55% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $183.00M | $176.23M | -3.70% | |
| $62.02M | $57.80M | -6.81% | |
| $65.55M | N/A | +13.41% | |
| $55.38M | N/A | -4.20% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -54.97% | ||
| -85.40% | ||
| -28.81% | ||
| -70.83% | ||
| -67.20% | ||
| -47.79% | ||
| +67.14% | ||
| +60.62% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.43 | ||
| $0.50 | ||
| SMA 200 vs Price | +16.70% | |
| $0.42 | ||
| SMA 50 vs Price | -2.71% | |
| 1.30 | ||
| $0.05 | ||
| 52.81 | ||
| 120.57% | ||
| 111.63% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $57.80M | ||
| -$0.49 | ||
| $48.44M | ||
| 83.80% | ||
| -$98.45M | ||
| -170.33% | ||
| -$97.94M | ||
| -169.45% | ||
| -$98.45M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 1.13 | ||
| 1.13 | ||
| - | ||
| 2 | ||
| -21.41 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 4.42 | ||
| 23.30 | ||
| -1.37 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $22.77M | ||
| $41.92M | ||
| $105.31M | ||
| $51.69M | ||
| $82.54M | ||
| $45.81M | ||
| $30.57M | ||
| $4.31M | ||
| $15.49M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $156.25M | ||
| $156.25M | ||
| $9.36M | ||
| $44.73M | ||
| $9.36M | ||
| $0.00 | ||
| -$167.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$67.14M | ||
| $37.52M | ||
| $28.38M | ||
| $267.00K | ||
| -$67.41M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Barclays | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Barclays | → | |
| HC Wainwright & Co. | → | |
| RBC Capital | → | |
| HC Wainwright & Co. | → | |
| Truist Securities | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with SGMO
FAQ
What is the ticker symbol for Sangamo Therapeutics, Inc.?
The ticker symbol for Sangamo Therapeutics, Inc. is NASDAQ:SGMO
Does Sangamo Therapeutics, Inc. pay dividends?
No, Sangamo Therapeutics, Inc. does not pay dividends
What sector is Sangamo Therapeutics, Inc. in?
Sangamo Therapeutics, Inc. is in the Healthcare sector
What industry is Sangamo Therapeutics, Inc. in?
Sangamo Therapeutics, Inc. is in the Biotechnology industry
What country is Sangamo Therapeutics, Inc. based in?
Sangamo Therapeutics, Inc. is headquartered in United States
When did Sangamo Therapeutics, Inc. go public?
Sangamo Therapeutics, Inc. initial public offering (IPO) was on April 6, 2000
Is Sangamo Therapeutics, Inc. in the S&P 500?
No, Sangamo Therapeutics, Inc. is not included in the S&P 500 index
Is Sangamo Therapeutics, Inc. in the NASDAQ 100?
No, Sangamo Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Sangamo Therapeutics, Inc. in the Dow Jones?
No, Sangamo Therapeutics, Inc. is not included in the Dow Jones index
When was Sangamo Therapeutics, Inc. last earnings report?
Sangamo Therapeutics, Inc.'s most recent earnings report was on November 6, 2025
When does Sangamo Therapeutics, Inc. report earnings?
The next expected earnings date for Sangamo Therapeutics, Inc. is March 16, 2026
Data Sources & References
- SGMO Official Website www.sangamo.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1001233/000100123325000024/0001001233-25-000024-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1001233/000162828025013088/0001628280-25-013088-index.htm
- SGMO Profile on Yahoo Finance finance.yahoo.com/quote/SGMO
- SGMO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/sgmo